Raymond James analyst Gary Nachman reiterated a Market Perform rating on Pacira Pharmaceuticals (NASDAQ: PCRX).The analyst comments "PCRX started the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE